UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC)

Endocrine-related cancer, 2006-06, Vol.13 (2), p.593-605

2006

Volltextzugriff (PDF)

Body mass index, waist circumference and waist-hip ratio and serum levels of IGF-I and IGFBP-3 in European women

Int J Obes (Lond), 2006-11, Vol.30 (11), p.1623-1631

2006

Volltextzugriff (PDF)

Several anthropometric measurements and breast cancer risk: results of the E3N cohort study

International Journal of Obesity, 2006-01, Vol.30 (1), p.156-163

2006

Volltextzugriff (PDF)

Incidence des gastroentérites à rotavirus chez les enfants de moins de cinq ans consultant un pédiatre ou un médecin généraliste en France

Pathologie biologie (Paris), 2013-06, Vol.61 (3), p.99-107

2013

Volltextzugriff (PDF)

Extra-cost of brain metastases in patients with non-squamous non-small cell lung cancer (NSCLC): A French national hospital database analysis

Annals of oncology, 2018-10, Vol.29, p.viii536-viii536

2018

Volltextzugriff (PDF)

Age at Menarche in Relation to Adult Height

American journal of epidemiology, 2005-10, Vol.162 (7), p.623-632

2005

Volltextzugriff (PDF)

Impact of Rotavirus gastroenteritis requiring hospitalization or presenting to emergency room among children less than 5 years in France

Pathologie biologie (Paris), 2012-10, Vol.60 (5), p.275-281

2012

Volltextzugriff (PDF)

Age at menarche in relation to adult height : The EPIC study

American journal of epidemiology, 2005-10, Vol.162 (7), p.623-632

2005

Volltextzugriff (PDF)

HTA354 Cross Analysis of HAS Conclusions Amongst Products with an Economic Opinion Posted in 2022

Value in health, 2023-12, Vol.26 (12), p.S388

2023

Volltextzugriff (PDF)

HTA65 Economic Evaluation of Medical Devices By the French National Authority (2014-2022): Where Do We Stand?

Value in health, 2023-12, Vol.26 (12), p.S331

2023

Volltextzugriff (PDF)

EE605 Methodological Acceptability of the Economic Analyses Assessed by the HAS in 2022

Value in health, 2023-12, Vol.26 (12), p.S169

2023

Volltextzugriff (PDF)

EE759 Willingness-To-Pay for a QALY: A New Approach to Estimate Cost-Effectiveness Threshold Applied to France

Value in health, 2023-12, Vol.26 (12), p.S200

2023

Volltextzugriff (PDF)

HTA212 Level of ICER of Health Economic Assessment in France in 2022

Value in health, 2023-12, Vol.26 (12), p.S360-S361

2023

Volltextzugriff (PDF)

Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC)

Public health nutrition, 2002-12, Vol.5 (6b), p.1147-1162

2002

Volltextzugriff (PDF)

PNS29 How Much Savings Mabthera's and Herceptin's Biosimilars Generated in France?

Value in health, 2020-12, Vol.23, p.S648-S648

2020

Volltextzugriff (PDF)

PMU74 Approximation of Time to Off Treatment Curves in Medico-Economic MODEL

Value in health, 2020-12, Vol.23, p.S615-S615

2020

Volltextzugriff (PDF)

Body silhouette, menstrual function at adolescence and breast cancer risk in the E3N cohort study

Breast cancer research and treatment, 2005-06, Vol.92 (11), p.2042-2048

2005

Volltextzugriff (PDF)

EE355 Budget Impact Model of a New rFVIIa (Eptacog Beta), for the On-Demand Treatment of Spontaneous Bleeding Events and Surgical Bleedings Among Hemophilia Patients with Inhibitors: A Payer Perspective From UK

Value in health, 2022-12, Vol.25 (12), p.S124-S124

2022

Volltextzugriff (PDF)

Programme d’étude évaluant l’impact de santé publique du remboursement de la spécialité InfanrixHexa®, en population générale et en médecine générale et pédiatrique. Études pharmaco-épidémiologiques réalisées à la demande des autorités de santé

Revue d'épidémiologie et de santé publique, 2014-02, Vol.62, p.S23-S23

2014

Volltextzugriff (PDF)

PRO122 ECONOMIC EVALUATION OF NUSINERSEN IN SPINAL MUSCULAR ATROPHY: A COMPARISON OF NICE AND HAS OPINIONS

Value in health, 2019-11, Vol.22, p.S863-S864

2019

Volltextzugriff (PDF)

Public health impact of Infanrix hexa™ (DTPa-HBV-IPV/Hib) reimbursement: A study programme in France. Part 2: Evolution of the acceptability of infants’ vaccination against hepatitis B in general and pediatric practices – the PRALINE study

Revue d'épidémiologie et de santé publique, 2016-06, Vol.64 (3), p.185-194

2016

Volltextzugriff (PDF)

Incidence of rotavirus gastroenteritis among children under 5 years consulting a paediatrician or a general practitioner in France

Pathologie biologie (Paris), 2013-06, Vol.61 (3), p.99-107

2013

Volltextzugriff (PDF)

Public health impact of Infanrix hexa™ (DTPa-HBV-IPV/Hib) reimbursement: A study programme in France. Part 1: Evolution of hepatitis B vaccine coverage rates in infants aged less than 27 months, in the general population – the PopCorn study

Revue d'épidémiologie et de santé publique, 2016-02, Vol.64 (1), p.23-32

2016

Volltextzugriff (PDF)

HTA16 Summary of Economic Evaluations on Onco-Hematology in France By the Has: What Did We Learn?

Value in health, 2023-12, Vol.26 (12), p.S323

2023

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(81)

Publikationsform

Artikel
(81)

Sprache

Englisch
(74)
Französisch
(7)

Erscheinungsjahr

n.n

Thema

Humans
(20)
Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Female
(19)
Middle Aged
(14)
Biological And Medical Sciences
(13)
Medical Sciences
(12)
Breast Cancer
(11)
Adult
(10)
Aged
(10)
Oncology
(10)
Body Mass Index
(8)
Internal Medicine
(8)
Male
(8)
Gynecology. Andrology. Obstetrics
(7)
Mammary Gland Diseases
(7)
Prospective Studies
(7)
Public, Environmental & Occupational Health
(7)
Risk Factors
(7)
Tumors
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC)

Body mass index, waist circumference and waist-hip ratio and serum levels of IGF-I and IGFBP-3 in European women

Polymorphisms of genes coding for insulin-like growth factor I and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk : results from the EPIC study

Several anthropometric measurements and breast cancer risk: results of the E3N cohort study

Incidence des gastroentérites à rotavirus chez les enfants de moins de cinq ans consultant un pédiatre ou un médecin généraliste en France

Extra-cost of brain metastases in patients with non-squamous non-small cell lung cancer (NSCLC): A French national hospital database analysis

Age at Menarche in Relation to Adult Height

Impact of Rotavirus gastroenteritis requiring hospitalization or presenting to emergency room among children less than 5 years in France

Age at menarche in relation to adult height : The EPIC study

HTA354 Cross Analysis of HAS Conclusions Amongst Products with an Economic Opinion Posted in 2022

HTA65 Economic Evaluation of Medical Devices By the French National Authority (2014-2022): Where Do We Stand?

EE605 Methodological Acceptability of the Economic Analyses Assessed by the HAS in 2022

EE759 Willingness-To-Pay for a QALY: A New Approach to Estimate Cost-Effectiveness Threshold Applied to France

HTA212 Level of ICER of Health Economic Assessment in France in 2022

Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC)

PNS29 How Much Savings Mabthera's and Herceptin's Biosimilars Generated in France?

PMU74 Approximation of Time to Off Treatment Curves in Medico-Economic MODEL

Body silhouette, menstrual function at adolescence and breast cancer risk in the E3N cohort study

EE355 Budget Impact Model of a New rFVIIa (Eptacog Beta), for the On-Demand Treatment of Spontaneous Bleeding Events and Surgical Bleedings Among Hemophilia Patients with Inhibitors: A Payer Perspective From UK

Programme d’étude évaluant l’impact de santé publique du remboursement de la spécialité InfanrixHexa®, en population générale et en médecine générale et pédiatrique. Études pharmaco-épidémiologiques réalisées à la demande des autorités de santé

PRO122 ECONOMIC EVALUATION OF NUSINERSEN IN SPINAL MUSCULAR ATROPHY: A COMPARISON OF NICE AND HAS OPINIONS

Public health impact of Infanrix hexa™ (DTPa-HBV-IPV/Hib) reimbursement: A study programme in France. Part 2: Evolution of the acceptability of infants’ vaccination against hepatitis B in general and pediatric practices – the PRALINE study

Incidence of rotavirus gastroenteritis among children under 5 years consulting a paediatrician or a general practitioner in France

Public health impact of Infanrix hexa™ (DTPa-HBV-IPV/Hib) reimbursement: A study programme in France. Part 1: Evolution of hepatitis B vaccine coverage rates in infants aged less than 27 months, in the general population – the PopCorn study

HTA16 Summary of Economic Evaluations on Onco-Hematology in France By the Has: What Did We Learn?

Suchergebnisse filtern